<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0000007'>autosomal-recessive</z:hpo> disorder Friedreich's <z:hpo ids='HP_0001251'>ataxia</z:hpo> is characterized by <z:hpo ids='HP_0002073'>progressive ataxia</z:hpo>, often in association with <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The most frequent cause of <z:hpo ids='HP_0011420'>death</z:hpo> is cardiac dysfunction, reflecting <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo>, <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and cardio-embolic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>With the discovery of the underlying genetic mutation, a variety of novel therapies are now progressing into clinical trials </plain></SENT>
<SENT sid="3" pm="."><plain>Consequently, it is crucial to understand the features of <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> in this disease and how new treatments may improve cardiac function </plain></SENT>
<SENT sid="4" pm="."><plain>The present artcle reviews the molecular basis of the disease, the clinical features of <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> in Friedreich's <z:hpo ids='HP_0001251'>ataxia</z:hpo> and the upcoming therapies </plain></SENT>
</text></document>